Workflow
MEMSensing(688286)
icon
Search documents
敏芯股份(688286) - 苏州敏芯微电子技术股份有限公司2024年年度股东大会决议公告
2025-05-16 11:30
证券代码:688286 证券简称:敏芯股份 公告编号:2025-038 苏州敏芯微电子技术股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 本次会议是否有被否决议案:无 一、 会议召开和出席情况 (一) 股东大会召开的时间:2025 年 5 月 16 日 (二) 股东大会召开的地点:中国(江苏)自由贸易试验区苏州片区苏州工业 园区旺家浜巷 8 号公司会议室 (三) 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况: | 1、出席会议的股东和代理人人数 | 32 | | --- | --- | | 普通股股东人数 | 32 | | 2、出席会议的股东所持有的表决权数量 | 18,021,857 | | 普通股股东所持有表决权数量 | 18,021,857 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 32.5720 | | 例(%) | | | 普通股股东所持有表决权数量占公司表决权数量的比例(%) | 32 ...
敏芯股份(688286) - 苏州敏芯微电子技术股份有限公司2024年年度股东大会会议资料
2025-05-08 10:15
2024 年年度股东大会会议资料 证券代码:688286 证券简称:敏芯股份 苏州敏芯微电子技术股份有限公司 2024 年年度股东大会 会议资料 二〇二五年五月 - 1 - 2024 年年度股东大会会议资料 | 2024 年年度股东大会会议须知 3 | | --- | | 年年度股东大会会议议程 5 2024 | | 2024 年年度股东大会会议议案 7 | | 议案一:《关于<公司 2024 年年度报告及其摘要>的议案》 7 | | 议案二:《关于<公司 年度董事会工作报告>的议案》 8 2024 | | 议案三:《关于<公司 2024 年度监事会工作报告>的议案》 17 | | 议案四:《关于<公司 2024 年度利润分配方案>的议案》 22 | | 议案五:《关于<公司 年度财务决算报告>的议案》 2024 23 | | 议案六:《关于<公司 2024 年度独立董事述职报告>的议案》 29 | | 议案七:《关于<公司 2025 年度董事薪酬方案>的议案》 30 | | 议案八:《关于<公司 2025 年度监事薪酬方案>的议案》 31 | | 议案九:《关于公司及子公司向银行申请综合授信额度并提供担保的 ...
敏芯股份:2024年营收稳步增长,技术创新与全品类矩阵未来可期-20250508
Tianfeng Securities· 2025-05-08 06:23
Investment Rating - The investment rating for the company is upgraded to "Buy" due to strong performance of new products and anticipated demand from AI applications [4][6]. Core Views - The company achieved a revenue of 506 million yuan in 2024, representing a year-on-year increase of 35.71%, and a net profit attributable to shareholders of -35.24 million yuan, a reduction in loss by 67 million yuan [1][4]. - The fourth quarter of 2024 saw a significant turnaround with a revenue of 169 million yuan, a year-on-year growth of 48.86%, and a net profit of 13 million yuan, marking a return to profitability [1][2]. - The company has made substantial progress in the pressure sensor business, with its revenue share increasing to 41.85%, up by 19.19 percentage points from the previous year [2][3]. Financial Performance - The company reported a comprehensive gross profit margin increase of 8.07 percentage points year-on-year, indicating a recovery in product profitability [2]. - Research and development expenses for 2024 were 80.97 million yuan, a 3.93% increase from the previous year, with 201 R&D personnel accounting for 33.06% of the total workforce [3]. - The company forecasts a net profit of 38.43 million yuan for 2025 and 66.16 million yuan for 2026, with a new estimate of 180 million yuan for 2027 [4][11]. Market Position and Strategy - The company is focusing on technological innovation and has made significant investments in R&D, particularly in AI-related products such as MEMS acoustic sensors and digital microphones [3]. - The product structure is continuously optimized, transitioning from a single product focus to a multi-product line strategy, enhancing its market position as a platform company based on MEMS technology [2][3]. - The company has initiated a share buyback program, repurchasing 425,399 shares, which represents 0.76% of the total share capital, to maintain investor interests [4].
敏芯股份(688286):2024年营收稳步增长,技术创新与全品类矩阵未来可期
Tianfeng Securities· 2025-05-08 04:17
Investment Rating - The investment rating for the company is upgraded to "Buy" due to strong performance of new products and anticipated demand from AI applications [4][6][17] Core Viewpoints - The company achieved a revenue of 506 million yuan in 2024, representing a year-on-year increase of 35.71%, and turned a profit in Q4 2024 with a net profit of 13 million yuan [1][2] - The pressure sensor business saw significant breakthroughs, with its revenue share rising to 41.85%, an increase of 19.19 percentage points year-on-year, indicating a successful transition to a multi-product line strategy [2][3] - The company continues to invest in R&D, with expenses reaching 80.97 million yuan in 2024, a 3.93% increase from the previous year, and a focus on developing new AI-related products [3][4] Financial Performance Summary - In 2024, the company reported a total revenue of 506.74 million yuan, with a growth rate of 35.71% compared to 2023 [5][11] - The EBITDA for 2024 was 112.72 million yuan, with a projected EBITDA of 91.59 million yuan for 2025 [5][11] - The net profit attributable to the parent company for 2024 was a loss of 35.24 million yuan, with forecasts of a profit of 38.43 million yuan in 2025 and 66.16 million yuan in 2026 [5][11] Market and Product Development - The company is focusing on the consumer electronics market, particularly the smartphone sector, which is showing improved demand [2] - New AI-related products, such as high signal-to-noise ratio digital microphones, are under development, with expectations for rapid growth in the AI sector [3][4] - The company has initiated a share buyback program, repurchasing 425,399 shares to enhance shareholder value [4]
国海证券晨会纪要-20250506
Guohai Securities· 2025-05-06 01:35
Group 1 - The core products of Zhaoli Pharmaceutical show stable growth, with a high dividend payout ratio maintained, achieving a revenue of 2.578 billion yuan in 2024, a year-on-year increase of 32.71% [8][9] - The company has significantly reduced costs and improved efficiency, with a notable decrease in expense ratios, including a sales expense ratio of 32.53%, down 7.5 percentage points year-on-year [9] - The company plans to implement an employee stock ownership plan by the end of 2024, with profit growth targets set at no less than 30% for 2025 [10] Group 2 - Weining Health's revenue for Q1 2025 was 345 million yuan, a year-on-year decrease of 30.24%, with a net profit of 5.29 million yuan, down 68.18% [11][12] - The company is focusing on cost reduction and efficiency improvement, with a significant increase in cash flow from operating activities, up 120.53% year-on-year [12] - The WiNEX product is entering a phase of mass delivery, supporting internet operations and international adaptation, with a strong digital architecture capable of handling millions of transactions [14][15] Group 3 - Lais Information's revenue for 2024 was 1.61 billion yuan, a year-on-year decrease of 3.94%, while Q1 2025 revenue dropped by 55.53% to 109 million yuan [17][18] - The company is optimizing its business structure, with significant growth in air traffic control and urban traffic management sectors, achieving revenue increases of 13.68% and 33.47% respectively [18][19] - The company is enhancing its research and development efforts, with a focus on refining its product offerings and improving operational efficiency [20] Group 4 - FenJung Media reported a revenue of 12.262 billion yuan in 2024, a year-on-year increase of 3.01%, with a net profit of 5.155 billion yuan, up 6.80% [23][25] - The company maintains a high dividend payout ratio, with cash dividends amounting to 4.766 billion yuan, representing 92.45% of net profit [24][25] - The planned acquisition of New潮传媒 is expected to enhance the company's competitive position in the outdoor advertising market [28] Group 5 - Jingwang Electronics achieved a revenue of 12.659 billion yuan in 2024, a year-on-year increase of 17.68%, with a net profit of 1.169 billion yuan, up 24.86% [30][31] - The company is expanding its production capacity, with a focus on high-end markets and AI applications, particularly in the automotive sector [32][33] - The company is increasing its R&D investments to support technological advancements and market expansion [33]
敏芯股份(688286) - 2025 Q1 - 季度财报
2025-04-29 11:00
Financial Performance - The company's revenue for Q1 2025 reached ¥134,962,790.04, representing a 53.05% increase compared to ¥88,183,289.62 in the same period last year[4] - Net profit attributable to shareholders was ¥2,848,652.80, a turnaround from a loss of ¥14,446,483.54 in the previous year[4] - The net cash flow from operating activities improved to ¥1,911,732.36, recovering from a negative cash flow of ¥31,122,293.18 in the prior year[4] - Operating profit for Q1 2025 was ¥2,869,177.29, recovering from a loss of ¥14,668,570.28 in Q1 2024[20] - Net profit for Q1 2025 was ¥2,780,434.85, compared to a net loss of ¥14,664,434.36 in the same period last year[21] - The company's total equity increased to ¥1,032,173,043.64 in Q1 2025, up from ¥1,028,379,236.19 in Q1 2024[20] Earnings and Margins - The basic earnings per share increased to ¥0.05, compared to a loss of ¥0.26 per share in the same period last year[4] - Basic earnings per share for Q1 2025 was ¥0.05, compared to a loss per share of ¥0.26 in Q1 2024[21] - The weighted average return on equity improved to 0.28%, an increase of 1.64 percentage points from -1.36% in the previous year[4] - The net profit attributable to shareholders increased by ¥1,729.51 million, driven by higher sales and improved gross margin[9] Cash Flow and Liquidity - The company reported a net increase of ¥3,303.40 million in cash flow from operating activities, primarily due to profit growth and inventory procurement[9] - Cash inflow from operating activities totaled ¥176,223,539.76 in Q1 2025, compared to ¥121,839,359.10 in Q1 2024, marking an increase of 44.7%[23] - The net cash flow from investing activities was $10,111,890.58, compared to a negative cash flow of $58,430,119.96 in the previous period[24] - The ending balance of cash and cash equivalents was $155,928,180.14, up from $139,423,521.69 in the previous period[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,198,646,770.94, a slight decrease of 1.01% from ¥1,210,873,724.91 at the end of the previous year[5] - Total current assets as of March 31, 2025, amount to ¥660,646,277.69, an increase from ¥645,563,445.92 as of December 31, 2024[15] - Total liabilities decreased to ¥166,473,727.30 in the latest quarter from ¥182,494,488.72 in the previous year, a reduction of 8.8%[20] - Total non-current assets decreased to ¥538,000,493.25 from ¥565,310,278.99[16] Research and Development - Research and development expenses totaled ¥16,712,765.83, accounting for 12.38% of revenue, down from 21.88% in the previous year, reflecting a decrease of 9.50 percentage points[5] - Research and development expenses decreased to ¥16,712,765.83 in Q1 2025 from ¥19,294,153.27 in Q1 2024, reflecting a reduction of 13.4%[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 7,021[11] - The largest shareholder, Li Gang, holds 10,745,026 shares, representing 19.19% of total shares[11] Other Financial Activities - The company did not apply new accounting standards starting from 2025[25] - The company received $20,000,000.00 in cash from borrowings during the financing activities[24] - Cash paid for debt repayment was $400,000.00, while cash paid for dividends and interest was $271,946.61[24] - The impact of exchange rate changes on cash and cash equivalents was -$8,446.06[24] - The company has no significant changes in the participation of major shareholders in margin trading and securities lending[13]
敏芯股份:2025一季报净利润0.03亿 同比增长121.43%
Tong Hua Shun Cai Bao· 2025-04-29 10:51
| 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 李刚 | 1074.50 | 19.19 | 不变 | | 中新苏州工业园区创业投资有限公司 | 249.93 | 4.46 | -30.00 | | 上海华芯创业投资企业 | 216.49 | 3.87 | -47.71 | | 苏州昶众企业管理咨询中心(有限合伙) | 185.00 | 3.30 | 不变 | | 梅嘉欣 | 167.04 | 2.98 | 不变 | | 胡维 | 158.50 | 2.83 | 不变 | | 信澳先进智造股票型 | 144.85 | 2.59 | 3.30 | | 苏州工业园区创业投资引导基金管理中心 | 124.23 | 2.22 | 不变 | | 信澳领先增长混合A | 116.03 | 2.07 | 12.10 | | 苏州昶恒企业管理咨询企业(有限合伙) | 93.86 | 1.68 | 不变 | 数据四舍五入,查看更多财务数据>> 一、主要会计数据和财务指标 二、前10名无限售条件股东持股情况 | 报告期指标 | 2025年一 ...
敏芯股份(688286):2024年业绩拐点初现,压力类产品与人形机器人产品驱动未来增长
Investment Rating - The investment rating for the company is "Buy" with a previous rating of "Buy" as well [1][5] Core Views - The company has shown a significant turnaround in its performance with a revenue growth of 35.7% year-on-year in 2024, and a substantial reduction in losses by 65.4% to RMB 0.4 billion. Notably, Q4 2024 marked the first quarter since 2022 where the company achieved a positive net profit attributable to shareholders [3][8] - The company's strategic focus on edge AI and humanoid robots is expected to drive future revenue growth, maintaining the "Buy" rating [3][5] Financial Summary - The company is projected to achieve a net profit attributable to shareholders of RMB 0.41 billion, RMB 0.97 billion, and RMB 1.59 billion for the years 2025, 2026, and 2027 respectively, with corresponding earnings per share of RMB 0.73, RMB 1.73, and RMB 2.84 [5][7] - The revenue for 2024 is expected to be RMB 5.06 billion, with a growth rate of 35.7%, and the EBITDA is projected to be RMB 4 million [7][9] - The gross margin for 2024 is reported at 24.9%, an increase of 8.1 percentage points year-on-year, while the net margin improved to -7.0%, up by 20.6 percentage points year-on-year [8][9] Business Performance - The company's MEMS pressure sensor revenue surged by 150.7% year-on-year, contributing significantly to the overall revenue growth, which is now diversified beyond a single growth driver [8] - The company has initiated several R&D projects targeting the demands of humanoid robots, including MEMS six-dimensional force/torque sensors and flexible pressure and temperature sensors [8]
敏芯股份(688286) - 上海博爱方本(苏州)律师事务所关于苏州敏芯微电子技术股份有限公司2025年第一次临时股东大会的法律意见书
2025-04-28 11:42
法律意见书 中国江苏省苏州市苏州工业园区圆融时代广场 24 幢苏州国寿金融中心 401 室 上海博爱方本(苏州)律师事务所 关于苏州敏芯微电子技术股份有限公司 上海博爱方本(苏州)律师事务所 关于苏州敏芯微电子技术股份有限公司 2025 年第一次临时股东大会的 2025 年第一次临时股东大会的 法律意见书 本法律意见书仅供公司为本次股东大会之目的而使用,不得被任何人用于其 他任何目的。本所同意,公司可以将本法律意见书作为公司本次股东大会公告材 料,随其他需要公告的信息一起向公众披露。 2 一、本次股东大会召集、召开的程序 (一)经本所律师查验,敏芯股份本次股东大会由董事会提议并召集,召开 本次股东大会的通知,已于 2025 年 4 月 10 日在《上海证券报》《证券时报》和 上海证券交易所网站(www.sse.com.cn)上公告。 根据本次股东大会的议程,提请本次股东大会审议的议题为: 致:苏州敏芯微电子技术股份有限公司 上海博爱方本(苏州)律师事务所(以下简称"本所")接受苏州敏芯微电子 技术股份有限公司(以下简称"敏芯股份"或"公司")的委托,指派本所律师出席 公司于 2025 年 4 月 28 日召开 ...
敏芯股份(688286) - 苏州敏芯微电子技术股份有限公司2025年第一次临时股东大会决议公告
2025-04-28 11:42
证券代码:688286 证券简称:敏芯股份 公告编号:2025-035 苏州敏芯微电子技术股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: (二) 股东大会召开的地点:中国(江苏)自由贸易试验区苏州片区苏州工业 园区旺家浜巷 8 号公司会议室 2、本次会议由公司董事会召集,董事长李刚先生主持; 3、本次会议的召集和召开程序以及表决方和表决程序符合《公司法》及《公 司章程》的规定,会议合法有效。 (五) 公司董事、监事和董事会秘书的出席情况 1、公司在任董事7人,出席7人; 2、公司在任监事3人,出席3人; 3、董事会秘书董铭彦先生出席了本次会议;其他高管列席本次会议。 (三) 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况: | 1、出席会议的股东和代理人人数 | 49 | | --- | --- | | 普通股股东人数 | 49 | | 2、出席会议的股东所持有的表决权数量 | 19,065,502 | | 普通股股东 ...